Document Detail


Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients.
MedLine Citation:
PMID:  19877067     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To describe the clinical and laboratory features of macrophage activation syndrome as a complication of juvenile systemic lupus erythematosus (SLE). METHODS: Cases of juvenile SLE-associated macrophage activation syndrome were provided by investigators belonging to 3 pediatric rheumatology networks or were found in the literature. Patients who had evidence of macrophage hemophagocytosis on bone marrow aspiration were considered to have definite macrophage activation syndrome, and those who did not have such evidence were considered to have probable macrophage activation syndrome. Clinical and laboratory findings in patients with macrophage activation syndrome were contrasted with those of 2 control groups composed of patients with active juvenile SLE without macrophage activation syndrome. The ability of each feature to discriminate macrophage activation syndrome from active disease was evaluated by calculating sensitivity, specificity, and area under the receiver operating characteristic curve. RESULTS: The study included 38 patients (20 with definite macrophage activation syndrome and 18 with probable macrophage activation syndrome). Patients with definite and probable macrophage activation syndrome were comparable with regard to all clinical and laboratory features of the syndrome, except for a greater frequency of lymphadenopathy, leukopenia, and thrombocytopenia in patients with definite macrophage activation syndrome. Overall, clinical features had better specificity than sensitivity, except for fever, which was highly sensitive but had low specificity. Among laboratory features, the best sensitivity and specificity was achieved using hyperferritinemia, followed by increased levels of lactate dehydrogenase, hypertriglyceridemia, and hypofibrinogenemia. Based on the results of statistical analysis, preliminary diagnostic guidelines for macrophage activation syndrome in juvenile SLE were developed. CONCLUSION: Our findings indicate that the occurrence of unexplained fever and cytopenia, when associated with hyperferritinemia, in a patient with juvenile SLE should raise the suspicion of macrophage activation syndrome. We propose preliminary guidelines for this syndrome in juvenile SLE to facilitate timely diagnosis and correct classification of patients.
Authors:
Alessandro Parodi; Sergio Dav??; Alejandra Beatriz Pringe; Angela Pistorio; Nicolino Ruperto; Silvia Magni-Manzoni; Paivi Miettunen; Brigitte Bader-Meunier; Graciela Espada; Gary Sterba; Seza Ozen; Dowain Wright; Claudia Saad Magalh??es; Raju Khubchandani; Hartmut Michels; Patricia Woo; Antonio Iglesias; Dinara Guseinova; Claudia Bracaglia; Kristen Hayward; Carine Wouters; Alexei Grom; Marina Vivarelli; Alberto Fischer; Luciana Breda; Alberto Martini; Angelo Ravelli;
Related Documents :
7076117 - Normal fasting-state levels of serum cholyl-conjugated bile acids in gilbert's syndrome...
3387877 - A simple bedside technique in the study of the wpw syndrome.
23505427 - Exploratory analysis of methods for automated classification of laboratory test orders ...
19423177 - The relationship and prognostic impact of low-t3 syndrome and nt-pro-bnp in cardiovascu...
19094857 - Yellow nails following hemodialysis in chronic renal failure: is it yellow nail syndrom...
23108157 - Genome-wide copy number variation study in anorectal malformations.
Publication Detail:
Type:  Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Arthritis and rheumatism     Volume:  60     ISSN:  0004-3591     ISO Abbreviation:  Arthritis Rheum.     Publication Date:  2009 Nov 
Date Detail:
Created Date:  2009-11-10     Completed Date:  2010-01-04     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0370605     Medline TA:  Arthritis Rheum     Country:  United States    
Other Details:
Languages:  eng     Pagination:  3388-99     Citation Subset:  AIM; IM    
Affiliation:
Istituto di Ricovero e Cura a Carattere Scientifico G. Gaslini, Genoa, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Child
Female
Ferritins / blood
Fever / diagnosis,  etiology
Humans
International Cooperation
Leukopenia / diagnosis,  etiology
Lupus Erythematosus, Systemic / complications*
Macrophage Activation Syndrome / blood,  diagnosis*,  etiology*
Male
Retrospective Studies
Thrombocytopenia / diagnosis,  etiology
Chemical
Reg. No./Substance:
9007-73-2/Ferritins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  DNA demethylation at specific CpG sites in the IL1B promoter in response to inflammatory cytokines i...
Next Document:  Whole-body bone scintigraphy provides a measure of the total-body burden of osteoarthritis for the p...